Author:
Helena Vaz Tolloto Gilce,Saragiotto Laiz
Abstract
Leaky gut syndrome is characterized by increased intestinal permeability, translocation of compounds such as toxins, lipopolysaccharides and bacteria from the intestinal microbiota involving pro-inflammatory processes, metabolic changes, and imbalance of lipid and lipid homeotase recent research has related increased intestinal permeability to metabolic syndrome, which is characterized mainly by insulin resistance, abdominal obesity, lipid disorders, prothrombotic and pro-inflammatory processes. The objective of this study is to analyze through the literature review the pathophysiological mechanisms and factors involved in the relationship of Leaky gut syndrome and metabolic syndrome. The research included 113 scientific articles published between 2014 and 2021 in Medline/Pubmed, Scielo and Lilacs databases. Were selected, fifity original academic articles, written in English, which were analyzed according to the year of publication, evaluation method, objectives and main results. The increase in intestinal permeability and alteration of the intestinal microbiota involved inflammatory, lipidic processes, alterations in glucose homeostasis and secretion of enteroendocrine peptides among them GLUT2 and GLP-1 evidencing a strong relationship in pathophysiological mechanisms in Leaky Gut syndrome and metabolic syndrome. Even studies in humans is rare, there is an intense interrelationship between microbiota, altered intestinal permeability in Leaky Gut Syndrome and Metabolic Syndrome.
Reference115 articles.
1. Águas M, Garrigues V, Bastida G, et al. Prevalência da síndrome do intestino irritável (SII) em parentes de primeiro grau de pacientes com doença inflamatória intestinal (DII). Colite de Crohn 2011; (5) :227-33.
2. Agwunobi AO, Reid C., Maycock P., Little RA, Carlson GL Resistência à insulina e utilização de substrato na endotoxemia humana. Journal of Clinical Endocrinology Metab. 2000; (85) :3770-3778.
3. Albaugh VL, Banan B., Antoun J., Xiong Y., Guo Y., Ping J., Alikhan M., Clements BA, Abumrad NN, Flynn CR Papel dos ácidos biliares e GLP-1 na mediação das melhorias metabólicas de Cirurgia Bariátrica. Gastroenterologia. 2019; (156) :1041-1051.
4. Alexander S, Bramson J, Foley R, Xing Z. Proteção contra endotoxemia por transferência de genes mediada por adenovírus de proteína humana bactericida/aumentadora de permeabilidade. Sangue. 2004; (103): 93-99.
5. Amyot J., Semache M., Ferdaoussi M., Fontés G., Poitout V. Os lipopolissacarídeos prejudicam a expressão do gene da insulina em ilhotas isoladas de Langerhans via Toll-Like Receptor-4 e sinalização NF-κB. PLoS UM. 2012; (7): e36200.